Neither Adam nor Eve seems worth very much anymore

Malignant eccrine spiradenoma of the vulva: a case report and review of the literature.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2006

Surgical management of epithelial ovarian cancer: a review of the literature.

Minerva ginecologica·2005

HPV infection and number of lifetime sexual partners are strong predictors for 'natural' regression of CIN 2 and 3.

British journal of cancer·2003

A randomized, double blind, Phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2001

Vaginal hysterectomy as primary treatment of endometrial cancer in medically compromised women.

Obstetrics and gynecology·2001

Primary invasive carcinoma of the vagina: treatment with interstitial brachytherapy.

Cancer·2001

Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groups.

Gynecologic oncology·2026

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial.

Gynecologic oncology·2026

Evaluating a patient ambassador program to improve clinical trial knowledge and intent to discuss gynecologic oncology trials.

Gynecologic oncology·2026

Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980-2023) with focus on younger women (0-49 years old).

Gynecologic oncology·2026

Predicting residual disease and extent of surgery after neoadjuvant chemotherapy for ovarian cancer: Does the MSKCC model from the primary setting apply?

Gynecologic oncology·2026

Feedback activation of MAPK-ERK1/2 signaling causes resistance to trastuzumab-deruxtecan in endometrial cancers.

Gynecologic oncology·2026

Retraction notice to "Inclusion of graphene on LDPE properties" [Heliyon 5 (2019) e02053].

Heliyon·2026

Related Experiment Videos

Neither Adam nor Eve seems worth very much anymore

Related Concept Videos

Malignant eccrine spiradenoma of the vulva: a case report and review of the literature.

Surgical management of epithelial ovarian cancer: a review of the literature.

HPV infection and number of lifetime sexual partners are strong predictors for 'natural' regression of CIN 2 and 3.

A randomized, double blind, Phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia.

Vaginal hysterectomy as primary treatment of endometrial cancer in medically compromised women.

Primary invasive carcinoma of the vagina: treatment with interstitial brachytherapy.

Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groups.

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial.

Evaluating a patient ambassador program to improve clinical trial knowledge and intent to discuss gynecologic oncology trials.

Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980-2023) with focus on younger women (0-49 years old).

Predicting residual disease and extent of surgery after neoadjuvant chemotherapy for ovarian cancer: Does the MSKCC model from the primary setting apply?

Feedback activation of MAPK-ERK1/2 signaling causes resistance to trastuzumab-deruxtecan in endometrial cancers.

Retraction notice to "Inclusion of graphene on LDPE properties" [Heliyon 5 (2019) e02053].

Related Experiment Videos

Neither Adam nor Eve seems worth very much anymore

Related Concept Videos

Related Articles